Safety and Efficacy of Raltegravir+TDF+3TC in HBV/HIV Co-infected Patients
NCT01318096
·
clinicaltrials.gov ↗
NA
Phase
UNKNOWN
Status
60
Enrollment
OTHER
Sponsor class
Conditions
HBV Coinfection
HIV Infections
Interventions
DRUG:
raltegravir and tenofovir and lamivudine
DRUG:
efavirenz+tenofovir+lamivudine
Sponsor
Yunnan AIDS Care Center